Huimin Wang Edwards Lifesciences Corp (EW) insider trading activity

Huimin Wang is CVP, Japan & Intercontinental of Edwards Lifesciences Corp. Currently has a direct ownership of 99,381 shares of EW, which is worth approximately $7.3 Million. The most recent transaction as insider was on Sep 08, 2021, when has been sold 6,350 shares (Common Stock) at a price of $121.25 per share, resulting in proceeds of $769,938. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.4K

0% 3M change

0% 12M change

Total Value Held $7.3 Million

HUIMIN WANG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 08 2021	SELL Open market or private sale	$769,938 $121.25 p/Share	6,350 Reduced 6.08%	98,026 Common Stock
Sep 08 2021	BUY Exercise of conversion of derivative security	$138,176 $21.76 p/Share	6,350 Added 5.73%	104,376 Common Stock
Aug 09 2021	SELL Open market or private sale	$733,679 $115.54 p/Share	6,350 Reduced 6.08%	98,026 Common Stock
Aug 09 2021	BUY Exercise of conversion of derivative security	$138,176 $21.76 p/Share	6,350 Added 5.73%	104,376 Common Stock
Jul 08 2021	SELL Open market or private sale	$677,672 $106.72 p/Share	6,350 Reduced 6.08%	98,026 Common Stock
Jul 08 2021	BUY Exercise of conversion of derivative security	$138,176 $21.76 p/Share	6,350 Added 5.73%	104,376 Common Stock
Jun 15 2021	SELL Open market or private sale	$641,350 $101.0 p/Share	6,350 Reduced 6.09%	97,889 Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	$138,176 $21.76 p/Share	6,350 Added 5.74%	104,239 Common Stock
May 17 2021	SELL Payment of exercise price or tax liability	$468,301 $89.49 p/Share	5,233 Reduced 5.07%	97,889 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	-	8,662 Added 7.75%	103,122 Common Stock
May 11 2021	SELL Payment of exercise price or tax liability	$98,536 $90.4 p/Share	1,090 Reduced 1.14%	94,460 Common Stock
May 07 2021	SELL Payment of exercise price or tax liability	$33,214 $91.75 p/Share	362 Reduced 0.35%	101,900 Common Stock
May 07 2021	SELL Open market or private sale	$583,375 $91.87 p/Share	6,350 Reduced 6.21%	95,912 Common Stock
May 07 2021	BUY Exercise of conversion of derivative security	$138,176 $21.76 p/Share	6,350 Added 5.85%	102,262 Common Stock
May 04 2021	BUY Grant, award, or other acquisition	-	2,475 Added 2.52%	95,912 Common Stock
Apr 08 2021	SELL Open market or private sale	$538,988 $84.88 p/Share	6,350 Reduced 6.36%	93,437 Common Stock
Apr 08 2021	BUY Exercise of conversion of derivative security	$138,176 $21.76 p/Share	6,350 Added 5.98%	99,787 Common Stock
Mar 08 2021	SELL Open market or private sale	$516,700 $81.37 p/Share	6,350 Reduced 6.38%	93,213 Common Stock
Mar 08 2021	BUY Exercise of conversion of derivative security	$138,176 $21.76 p/Share	6,350 Added 6.0%	99,563 Common Stock
Feb 11 2021	SELL Open market or private sale	$1,019,583 $86.81 p/Share	11,745 Reduced 11.19%	93,213 Common Stock
Feb 11 2021	BUY Exercise of conversion of derivative security	$163,021 $13.98 p/Share	11,661 Added 10.0%	104,958 Common Stock
Jan 15 2021	SELL Open market or private sale	$1,023,677 $87.27 p/Share	11,730 Reduced 11.17%	93,297 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$162,853 $13.98 p/Share	11,649 Added 9.98%	105,027 Common Stock
Dec 14 2020	SELL Open market or private sale	$994,137 $84.73 p/Share	11,733 Reduced 11.16%	93,378 Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$162,853 $13.98 p/Share	11,649 Added 9.98%	105,111 Common Stock

Huimin Wang

CVP, Japan & Intercontinental

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account